SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-056280
Filing Date
2020-05-04
Accepted
2020-05-04 17:07:36
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tm2014512d1_10q.htm 10-Q 504601
2 EXHIBIT 31.1 tm2014512d1_ex31-1.htm EX-31.1 7666
3 EXHIBIT 31.2 tm2014512d1_ex31-2.htm EX-31.2 7514
4 EXHIBIT 32.1 tm2014512d1_ex32-1.htm EX-32.1 3539
5 EXHIBIT 32.2 tm2014512d1_ex32-2.htm EX-32.2 3795
  Complete submission text file 0001104659-20-056280.txt   3719977

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20200331_lab.xml EX-101.LAB 381695
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20200331_pre.xml EX-101.PRE 258851
8 XBRL INSTANCE DOCUMENT cycn-20200331.xml EX-101.INS 754764
9 XBRL TAXONOMY EXTENSION SCHEMA cycn-20200331.xsd EX-101.SCH 42427
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycn-20200331_cal.xml EX-101.CAL 50609
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycn-20200331_def.xml EX-101.DEF 122569
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 20845772
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences